speb/financial-data huggingface dataset:
QGEN balance_sheet (quarterly, 2025-03-31) — Net PPE: 803661000.00
QGEN cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -43902000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 668727000.00
QGEN income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 180567000.00
QGEN income_statement (quarterly, 2025-03-31) — Normalized Income: 98210011.54
QGEN cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 139740000.00
QGEN cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 968000.00
QGEN income_statement (quarterly, 2025-03-31) — Operating Income: 125163000.00
QGEN income_statement (quarterly, 2025-03-31) — Operating Revenue: 483456000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 205728455.00
QGEN balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 144192000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 55693000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 3718000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -441646000.00
QGEN income_statement (quarterly, 2025-03-31) — Other Gand A: 31608000.00
QGEN income_statement (quarterly, 2025-03-31) — Other Income Expense: -13710000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 290503000.00
QGEN cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 4375000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 259687000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 267493000.00
QGEN income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -3894000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 324689000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Payables: 69666000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 457533000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
QGEN income_statement (quarterly, 2025-03-31) — Pretax Income: 119549000.00
QGEN cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -362000.00
QGEN cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -26260000.00
QGEN cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -43902000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Raw Materials: 54573000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Receivables: 340706000.00
QGEN income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 132660000.00
QGEN income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 43908000.00
QGEN income_statement (quarterly, 2025-03-31) — Research And Development: 43783000.00
QGEN income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 9816000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 2498974000.00
QGEN cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 189679000.00
QGEN income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 106334000.00
QGEN income_statement (quarterly, 2025-03-31) — Selling General And Administration: 137942000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Share Issued: 206801005.00
QGEN income_statement (quarterly, 2025-03-31) — Special Income Charges: -9816000.00
QGEN cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 12339000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 3407877000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 668727000.00
QGEN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -2363988.46
QGEN income_statement (quarterly, 2025-03-31) — Tax Provision: 28791000.00
QGEN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.24
QGEN balance_sheet (quarterly, 2025-03-31) — Total Assets: 5545369000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 4760523000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Total Debt: 1408339000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 3407877000.00
QGEN income_statement (quarterly, 2025-03-31) — Total Expenses: 358293000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2137492000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 3802498000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1620548000.00
QGEN income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 115347000.00
QGEN income_statement (quarterly, 2025-03-31) — Total Unusual Items: -9816000.00
QGEN income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -9816000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 1072550.00
QGEN balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 50236000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Work In Process: 74312000.00
QGEN balance_sheet (quarterly, 2025-03-31) — Working Capital: 1225927000.00
QGEN income_statement (quarterly, 2025-03-31) — Write Off: 2500000.00
QGEN income_statement (quarterly, 2025-06-30) — +Operating Expense: 198312000.00
QGEN income_statement (quarterly, 2025-06-30) — +Total Revenue: 533540000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 82339000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 385758000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -603589000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1409013000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -22365000.00
QGEN income_statement (quarterly, 2025-06-30) — Amortization: 1817000.00
QGEN income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 1817000.00
QGEN cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
QGEN income_statement (quarterly, 2025-06-30) — Basic Average Shares: 205866900.00
QGEN income_statement (quarterly, 2025-06-30) — Basic EPS: 0.46
QGEN cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 638756000.00
QGEN cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -40836000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2529000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 733815000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 953815000.00
QGEN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -27994000.00
QGEN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -41997000.00
QGEN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 161435000.00
QGEN cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 12357000.00
QGEN cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -10423000.00
QGEN cash_flow (quarterly, 2025-06-30) — Change In Inventory: 3321000.00
QGEN cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -768000.00
QGEN cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 1682000.00
QGEN cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 12818000.00
QGEN cash_flow (quarterly, 2025-06-30) — Change In Payable: 12357000.00
QGEN cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 1934000.00
QGEN cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 12139000.00
QGEN cash_flow (quarterly, 2025-06-30) — Change In Receivables: -35257000.00
QGEN cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -4131000.00
QGEN cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -35257000.00
QGEN cash_flow (quarterly, 2025-06-30) — Changes In Cash: 91444000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Common Stock: 2529000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 3505490000.00
QGEN income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 199254000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 482227000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Current Assets: 1818989000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Current Debt: 559187000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 559187000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1128314000.00
QGEN cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 3717000.00
QGEN cash_flow (quarterly, 2025-06-30) — Deferred Tax: 3717000.00
QGEN cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 49478000.00
QGEN income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 1817000.00
QGEN cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 49478000.00
QGEN income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 1817000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 0.00
QGEN income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 207273850.00
QGEN income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.46
QGEN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 96250000.00
QGEN income_statement (quarterly, 2025-06-30) — EBIT: 134426000.00
QGEN income_statement (quarterly, 2025-06-30) — EBITDA: 183904000.00
QGEN income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 1300000.00
QGEN cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 3615000.00
QGEN cash_flow (quarterly, 2025-06-30) — End Cash Position: 733815000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Financial Assets: 0.00
QGEN cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -27994000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Finished Goods: 163873000.00
QGEN cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 120599000.00
QGEN cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 0.00
QGEN income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -2600000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -387664000.00
QGEN income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 30648000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Goodwill: 2551990000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 2866232000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 408123000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Gross PPE: 1478538000.00
QGEN income_statement (quarterly, 2025-06-30) — Gross Profit: 334286000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Hedging Assets Current: 14772000.00
QGEN income_statement (quarterly, 2025-06-30) — Interest Expense: 7605000.00
QGEN income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 7605000.00
QGEN income_statement (quarterly, 2025-06-30) — Interest Income: 13859000.00
QGEN income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 13859000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Inventory: 292550000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Invested Capital: 4949526000.00
QGEN cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -41997000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 884849000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 884849000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Net Debt: 710221000.00
QGEN income_statement (quarterly, 2025-06-30) — Net Income: 96250000.00
QGEN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 96250000.00
QGEN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 96250000.00
QGEN income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 96250000.00
QGEN income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 96250000.00
QGEN cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 96250000.00
QGEN income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 96250000.00
QGEN cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -646000.00
QGEN income_statement (quarterly, 2025-06-30) — Net Interest Income: 6254000.00
QGEN cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 102406000.00
QGEN income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 6254000.00
QGEN cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 252092000.00
QGEN cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -36972000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Net PPE: 874949000.00
QGEN cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -40190000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 639258000.00
QGEN income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 200576000.00
QGEN income_statement (quarterly, 2025-06-30) — Normalized Income: 108904048.00
QGEN cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 161435000.00
QGEN cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 0.00
QGEN income_statement (quarterly, 2025-06-30) — Operating Income: 135974000.00
QGEN income_statement (quarterly, 2025-06-30) — Operating Revenue: 533540000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 205992555.00
QGEN balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 172094000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 559187000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 4561000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -387664000.00
QGEN income_statement (quarterly, 2025-06-30) — Other Gand A: 30648000.00
QGEN income_statement (quarterly, 2025-06-30) — Other Income Expense: -15372000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 314242000.00
QGEN cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 5364000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 263588000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 305105000.00
QGEN income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -1335000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 220000000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Payables: 82339000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 564566000.00
QGEN income_statement (quarterly, 2025-06-30) — Pretax Income: 126821000.00
QGEN cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -646000.00
QGEN cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -109972000.00
QGEN cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -40190000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Raw Materials: 53889000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Receivables: 385758000.00
QGEN income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 151593000.00
QGEN income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 49478000.00
QGEN income_statement (quarterly, 2025-06-30) — Research And Development: 47750000.00
QGEN income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 14072000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 2517965000.00
QGEN cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 212378000.00
QGEN income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 118097000.00
QGEN income_statement (quarterly, 2025-06-30) — Selling General And Administration: 148745000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Share Issued: 206801005.00
QGEN income_statement (quarterly, 2025-06-30) — Special Income Charges: -14072000.00
QGEN cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 10757000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 3505490000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 639258000.00
QGEN income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -3392144.14
QGEN income_statement (quarterly, 2025-06-30) — Tax Provision: 30571000.00
QGEN income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.24
QGEN balance_sheet (quarterly, 2025-06-30) — Total Assets: 5823758000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 4390339000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Total Debt: 1444036000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 3505490000.00
QGEN income_statement (quarterly, 2025-06-30) — Total Expenses: 397566000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2318268000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 4004769000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 1189954000.00
QGEN income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 121902000.00
QGEN income_statement (quarterly, 2025-06-30) — Total Unusual Items: -16672000.00
QGEN income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -16672000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 808450.00
QGEN balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 36353000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Work In Process: 74788000.00
QGEN balance_sheet (quarterly, 2025-06-30) — Working Capital: 690675000.00
QGEN income_statement (quarterly, 2025-09-30) — +Operating Expense: 193966000.00
QGEN income_statement (quarterly, 2025-09-30) — +Total Revenue: 532583000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 74771000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 375562000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -621288000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1419717000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -21820000.00
QGEN income_statement (quarterly, 2025-09-30) — Amortization: 2112000.00
QGEN income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 2112000.00
QGEN cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
QGEN income_statement (quarterly, 2025-09-30) — Basic Average Shares: 206027450.00
QGEN income_statement (quarterly, 2025-09-30) — Basic EPS: 0.63
QGEN cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 733815000.00
QGEN cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -50447000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Capital Stock: 2529000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1355594000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1689970000.00
QGEN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 614069000.00
QGEN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -156897000.00
QGEN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 165019000.00
QGEN cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -12708000.00
QGEN cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -18881000.00
QGEN cash_flow (quarterly, 2025-09-30) — Change In Inventory: -939000.00
QGEN cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 449000.00
QGEN cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -2784000.00
QGEN cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 2427000.00
QGEN cash_flow (quarterly, 2025-09-30) — Change In Payable: -12708000.00
QGEN cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -31589000.00
QGEN cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -2538000.00
QGEN cash_flow (quarterly, 2025-09-30) — Change In Receivables: 8552000.00
QGEN cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -26422000.00
QGEN cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 8552000.00
QGEN cash_flow (quarterly, 2025-09-30) — Changes In Cash: 622191000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Common Stock: 2529000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 3649415000.00
QGEN cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
QGEN income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 201324000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 399034000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Current Assets: 2530937000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Current Debt: 499600000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 499600000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 973405000.00
QGEN cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -3478000.00
QGEN cash_flow (quarterly, 2025-09-30) — Deferred Tax: -3478000.00
QGEN cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 50966000.00
QGEN income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 2112000.00
QGEN cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 50966000.00
QGEN income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 2112000.00
QGEN income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 207530350.00
QGEN income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.63
QGEN income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 130043000.00
QGEN income_statement (quarterly, 2025-09-30) — EBIT: 142944000.00
QGEN income_statement (quarterly, 2025-09-30) — EBITDA: 193910000.00
QGEN cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -412000.00
QGEN cash_flow (quarterly, 2025-09-30) — End Cash Position: 1355594000.00
QGEN cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 614069000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Finished Goods: 165557000.00
QGEN cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 114572000.00
QGEN cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 0.00
QGEN balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -384323000.00
QGEN income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 30287000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Goodwill: 2554475000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 2851654000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 397382000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1518930000.00
QGEN income_statement (quarterly, 2025-09-30) — Gross Profit: 331259000.00
QGEN income_statement (quarterly, 2025-09-30) — Interest Expense: 8218000.00
QGEN income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 8218000.00
QGEN income_statement (quarterly, 2025-09-30) — Interest Income: 15070000.00
QGEN income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 15070000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Inventory: 290226000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Invested Capital: 5776607000.00
QGEN cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -156897000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1627592000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1627592000.00
QGEN cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -60167000.00
QGEN cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
QGEN cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
QGEN balance_sheet (quarterly, 2025-09-30) — Net Debt: 771598000.00
QGEN income_statement (quarterly, 2025-09-30) — Net Income: 130043000.00
QGEN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 130043000.00
QGEN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 130043000.00
QGEN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 130043000.00
QGEN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 130043000.00
QGEN cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 130043000.00
QGEN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 130043000.00
QGEN cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -4402000.00
QGEN income_statement (quarterly, 2025-09-30) — Net Interest Income: 6852000.00
QGEN cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -114459000.00
QGEN cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 684461000.00
QGEN cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 684461000.00
QGEN income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 6852000.00
QGEN cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -16148000.00
QGEN cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 8009000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Net PPE: 897642000.00
QGEN cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -46045000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 797761000.00
QGEN income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 202040000.00
QGEN income_statement (quarterly, 2025-09-30) — Normalized Income: 137888450.00
QGEN cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 165019000.00
QGEN cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 0.00
QGEN income_statement (quarterly, 2025-09-30) — Operating Income: 137293000.00
QGEN income_statement (quarterly, 2025-09-30) — Operating Revenue: 532583000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 205998950.00
QGEN balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 175179000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -384323000.00
QGEN income_statement (quarterly, 2025-09-30) — Other Gand A: 30287000.00
QGEN income_statement (quarterly, 2025-09-30) — Other Income Expense: -9419000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 297179000.00
QGEN cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 3201000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 273264000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 303085000.00
QGEN income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -1289000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 334376000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Payables: 74771000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 473805000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
QGEN income_statement (quarterly, 2025-09-30) — Pretax Income: 134726000.00
QGEN cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
QGEN cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -4402000.00
QGEN cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -234459000.00
QGEN cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -46045000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Raw Materials: 51004000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Receivables: 375562000.00
QGEN income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 152470000.00
QGEN income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 50966000.00
QGEN cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -60167000.00
QGEN cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
QGEN income_statement (quarterly, 2025-09-30) — Research And Development: 48748000.00
QGEN income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 8130000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 2647574000.00
QGEN cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 120000000.00
QGEN income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 112819000.00
QGEN income_statement (quarterly, 2025-09-30) — Selling General And Administration: 143106000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Share Issued: 206800750.00
QGEN income_statement (quarterly, 2025-09-30) — Special Income Charges: -8130000.00
QGEN cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 10709000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 3649415000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 797761000.00
QGEN income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -284550.00
QGEN income_statement (quarterly, 2025-09-30) — Tax Provision: 4683000.00
QGEN income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.04
QGEN balance_sheet (quarterly, 2025-09-30) — Total Assets: 6553497000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 5277007000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Total Debt: 2127192000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 3649415000.00
QGEN income_statement (quarterly, 2025-09-30) — Total Expenses: 395290000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2904082000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 4022560000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1930677000.00
QGEN income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 129163000.00
QGEN income_statement (quarterly, 2025-09-30) — Total Unusual Items: -8130000.00
QGEN income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -8130000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 801800.00
QGEN balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 36082000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Work In Process: 73665000.00
QGEN balance_sheet (quarterly, 2025-09-30) — Working Capital: 1557532000.00
QGEN income_statement (annual, 2025-12-31) — +Operating Expense: 779185000.00
QGEN income_statement (quarterly, 2025-12-31) — +Operating Expense: 203389000.00
QGEN income_statement (annual, 2025-12-31) — +Total Revenue: 2089999000.00
QGEN income_statement (quarterly, 2025-12-31) — +Total Revenue: 540420000.00
QGEN balance_sheet (annual, 2025-12-31) — Accounts Payable: 72656000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 72656000.00
QGEN balance_sheet (annual, 2025-12-31) — Accounts Receivable: 402608000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 402608000.00
QGEN balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -464965000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -464965000.00
QGEN balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1436360000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1436360000.00
QGEN balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -19538000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -19538000.00
QGEN income_statement (annual, 2025-12-31) — Amortization: 8000000.00
QGEN income_statement (quarterly, 2025-12-31) — Amortization: 2278000.00
QGEN income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 8000000.00
QGEN income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 2278000.00
QGEN cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 22440000.00
QGEN cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 19903000.00
QGEN income_statement (annual, 2025-12-31) — Basic Average Shares: 206074698.00
QGEN income_statement (quarterly, 2025-12-31) — Basic Average Shares: 206074698.00
QGEN income_statement (annual, 2025-12-31) — Basic EPS: 2.06
QGEN income_statement (quarterly, 2025-12-31) — Basic EPS: 0.52
QGEN cash_flow (annual, 2025-12-31) — Beginning Cash Position: 663555000.00
QGEN cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1355594000.00
QGEN balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 409379000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 409379000.00
QGEN cash_flow (annual, 2025-12-31) — Capital Expenditure: -207126000.00
QGEN cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -71579000.00
QGEN balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 157944000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 157944000.00
QGEN balance_sheet (annual, 2025-12-31) — Capital Stock: 2529000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2529000.00
QGEN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 839005000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 839005000.00
QGEN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1098918000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1098918000.00
QGEN cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -54243000.00
QGEN cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 1000.00
QGEN balance_sheet (annual, 2025-12-31) — Cash Equivalents: 702462000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 702462000.00
QGEN balance_sheet (annual, 2025-12-31) — Cash Financial: 136543000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Cash Financial: 136543000.00
QGEN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -178976000.00
QGEN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -478347000.00
QGEN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -305279000.00
QGEN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -226466000.00
QGEN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 654326000.00
QGEN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 188132000.00
QGEN cash_flow (annual, 2025-12-31) — Change In Account Payable: -8418000.00
QGEN cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -2099000.00
QGEN cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -42821000.00
QGEN cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 25343000.00
QGEN cash_flow (annual, 2025-12-31) — Change In Inventory: -848000.00
QGEN cash_flow (quarterly, 2025-12-31) — Change In Inventory: -5401000.00
QGEN cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -1712000.00
QGEN cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -2106000.00
QGEN cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 38341000.00
QGEN cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 38842000.00
QGEN cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 14316000.00
QGEN cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -29922000.00
QGEN cash_flow (annual, 2025-12-31) — Change In Payable: -8418000.00
QGEN cash_flow (quarterly, 2025-12-31) — Change In Payable: -2099000.00
QGEN cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -51239000.00
QGEN cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 23244000.00
QGEN cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 3021000.00
QGEN cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 8621000.00
QGEN cash_flow (annual, 2025-12-31) — Change In Receivables: -36392000.00
QGEN cash_flow (quarterly, 2025-12-31) — Change In Receivables: -22635000.00
QGEN cash_flow (annual, 2025-12-31) — Change In Working Capital: -34513000.00
QGEN cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 10643000.00
QGEN cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -36392000.00
QGEN cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -22635000.00
QGEN cash_flow (annual, 2025-12-31) — Changes In Cash: 170071000.00
QGEN cash_flow (quarterly, 2025-12-31) — Changes In Cash: -516681000.00
QGEN balance_sheet (annual, 2025-12-31) — Common Stock: 2529000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Common Stock: 2529000.00
QGEN cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -54243000.00
QGEN cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: 1000.00
QGEN balance_sheet (annual, 2025-12-31) — Common Stock Equity: 3778154000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 3778154000.00
QGEN balance_sheet (annual, 2025-12-31) — Construction In Progress: 269347000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 269347000.00
QGEN income_statement (annual, 2025-12-31) — Cost Of Revenue: 790504000.00
QGEN income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 215151000.00
QGEN balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 197256000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 197256000.00
QGEN balance_sheet (annual, 2025-12-31) — Current Assets: 1995073000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Current Assets: 1995073000.00
QGEN balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 28837000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 28837000.00
QGEN balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 28837000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 28837000.00
QGEN balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 79423000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 79423000.00
QGEN balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 79423000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 79423000.00
QGEN balance_sheet (annual, 2025-12-31) — Current Liabilities: 512137000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 512137000.00
QGEN cash_flow (annual, 2025-12-31) — Deferred Income Tax: -20067000.00
QGEN cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -19764000.00
QGEN cash_flow (annual, 2025-12-31) — Deferred Tax: -20067000.00
QGEN cash_flow (quarterly, 2025-12-31) — Deferred Tax: -19764000.00
QGEN cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 193746000.00
QGEN cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 49394000.00
QGEN income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 8000000.00
QGEN income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 2278000.00
QGEN cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 193746000.00
QGEN cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 49394000.00
QGEN income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 8000000.00
QGEN income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 2278000.00
QGEN income_statement (annual, 2025-12-31) — Diluted Average Shares: 207936000.00
QGEN income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 207761200.00
QGEN income_statement (annual, 2025-12-31) — Diluted EPS: 2.04
QGEN income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.52
QGEN income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 424880000.00
QGEN income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 107829000.00
QGEN income_statement (annual, 2025-12-31) — EBIT: 523521000.00
QGEN income_statement (quarterly, 2025-12-31) — EBIT: 119308000.00
QGEN income_statement (annual, 2025-12-31) — EBITDA: 717267000.00
QGEN income_statement (quarterly, 2025-12-31) — EBITDA: 168702000.00
QGEN cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 5379000.00
QGEN cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 92000.00
QGEN cash_flow (annual, 2025-12-31) — End Cash Position: 839005000.00
QGEN cash_flow (quarterly, 2025-12-31) — End Cash Position: 839005000.00
QGEN cash_flow (annual, 2025-12-31) — Financing Cash Flow: -178976000.00
QGEN cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -478347000.00
QGEN balance_sheet (annual, 2025-12-31) — Finished Goods: 169306000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Finished Goods: 169306000.00
QGEN cash_flow (annual, 2025-12-31) — Free Cash Flow: 447200000.00
QGEN cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 116553000.00
QGEN cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 968000.00
QGEN cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 0.00
QGEN balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -377309000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -377309000.00
QGEN income_statement (annual, 2025-12-31) — General And Administrative Expense: 125676000.00
QGEN income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 33133000.00
QGEN balance_sheet (annual, 2025-12-31) — Goodwill: 2700658000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Goodwill: 2700658000.00
QGEN balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 3087089000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 3087089000.00
QGEN balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 422146000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 422146000.00
QGEN balance_sheet (annual, 2025-12-31) — Gross PPE: 1542057000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1542057000.00
QGEN income_statement (annual, 2025-12-31) — Gross Profit: 1299495000.00
QGEN income_statement (quarterly, 2025-12-31) — Gross Profit: 325269000.00
QGEN balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 2448000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 2448000.00
QGEN cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 17266000.00
QGEN balance_sheet (annual, 2025-12-31) — Income Tax Payable: 39717000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 39717000.00
QGEN income_statement (annual, 2025-12-31) — Interest Expense: 33256000.00
QGEN income_statement (quarterly, 2025-12-31) — Interest Expense: 10139000.00
QGEN income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 33256000.00
QGEN income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 10139000.00
QGEN income_statement (annual, 2025-12-31) — Interest Income: 64320000.00
QGEN income_statement (quarterly, 2025-12-31) — Interest Income: 20001000.00
QGEN income_statement (annual, 2025-12-31) — Interest Income Non Operating: 64320000.00
QGEN income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 20001000.00
QGEN cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 29252000.00
QGEN balance_sheet (annual, 2025-12-31) — Interest Payable: 13796000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Interest Payable: 13796000.00
QGEN balance_sheet (annual, 2025-12-31) — Inventory: 301888000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Inventory: 301888000.00
QGEN balance_sheet (annual, 2025-12-31) — Invested Capital: 5432582000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Invested Capital: 5432582000.00
QGEN cash_flow (annual, 2025-12-31) — Investing Cash Flow: -305279000.00
QGEN cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -226466000.00
QGEN cash_flow (annual, 2025-12-31) — Issuance Of Debt: 742318000.00
QGEN cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: -2310000.00
QGEN balance_sheet (annual, 2025-12-31) — Land And Improvements: 27618000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 27618000.00
QGEN balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 129107000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 129107000.00
QGEN balance_sheet (annual, 2025-12-31) — Long Term Debt: 1654428000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 1654428000.00
QGEN balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1783535000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1783535000.00
QGEN cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 742318000.00
QGEN cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: -2310000.00
QGEN cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -534167000.00
QGEN cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -474000000.00
QGEN balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 682569000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 682569000.00
QGEN cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -291227000.00
QGEN cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -224632000.00
QGEN balance_sheet (annual, 2025-12-31) — Net Debt: 815423000.00
QGEN balance_sheet (quarterly, 2025-12-31) — Net Debt: 815423000.00
QGEN income_statement (annual, 2025-12-31) — Net Income: 424880000.00
QGEN income_statement (quarterly, 2025-12-31) — Net Income: 107829000.00
QGEN income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 424880000.00
QGEN income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 107829000.00
QGEN income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 424880000.00
QGEN income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 107829000.00
QGEN income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 424880000.00
QGEN income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 107829000.00
QGEN income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 424880000.00
QGEN income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 107829000.00
QGEN cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 424880000.00
QGEN cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 107829000.00
QGEN income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 424880000.00
QGEN income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 107829000.00
QGEN cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -6077000.00
QGEN cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -667000.00
QGEN income_statement (annual, 2025-12-31) — Net Interest Income: 31064000.00
QGEN income_statement (quarterly, 2025-12-31) — Net Interest Income: 9862000.00
QGEN cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 225237000.00
QGEN cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 73871000.00
QGEN cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 208151000.00
QGEN cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -476310000.00
QGEN cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 208151000.00
QGEN cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -476310000.00
QGEN income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 31064000.00
QGEN income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 9862000.00
QGEN cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -332884000.00
QGEN cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -282124000.00
QGEN cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -32163000.00
QGEN cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -4126000.00